Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Interaction Map Network Comparison Type Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 19220 to 19269 of 25824 in total
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Value Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{5}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2403\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dymeclin. [source:refseq;acc:nm\_017653]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
26996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28788.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
likely ortholog of mouse shc sh2-domain binding protein 1. [source:refseq;acc:nm\_024745]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15953.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17274.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1321.2\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln64 n-terminal domain homolog (stard3 n-terminal like protein). [source:swissprot;acc:o95772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
60.8344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
61.7685\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01535\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pdz/coiled-coil domain binding partner for the rho-family gtpase tc10; fused in glioblastoma; golgi associated pdz and coiled-coil motif containing protein; cftr-associated ligand. [source:refseq;acc:nm\_020399]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
5978.83\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6166.89\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
188.06\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2404\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l13a (23 kda highly basic protein). [source:swissprot;acc:p40429]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
13245.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14566.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1320.8\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l3-like. [source:swissprot;acc:q92901]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
3617.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3430.31\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
187.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coenzyme a oxidase 2, peroxisomal (ec 1.3.3.6) (branched-chain acyl-coa oxidase) (brcacox) (trihydroxycoprostanoyl-coa oxidase) (thccox) (thca-coa oxidase). [source:swissprot;acc:q99424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.105\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0037\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 3 (cap3) (cap-3) (protease inhibitor 9) (serpin b9). [source:swissprot;acc:p50453]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.6893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.7518\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.9375\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-beta (liver x receptor beta) (nuclear orphan receptor lxr-beta) (ubiquitously-expressed nuclear receptor) (nuclear receptor ner). [source:swissprot;acc:p55055]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich-like protein. [source:swissprot;acc:o75368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
26996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28788.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
57.6124\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
58.4763\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.015\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2405\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.6893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.7518\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.9375\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich protein 1 (crp1) (crp). [source:swissprot;acc:p21291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15945.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
17266.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1320.6\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxyacid oxidase 2 (ec 1.1.3.15) (haox2) ((s)-2-hydroxy-acid oxidase, peroxisomal) (long chain alpha-hydroxy acid oxidase) (long- chain l-2-hydroxy acid oxidase). [source:swissprot;acc:q9nyq3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
4457.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4642.72\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
185.12\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxyindole o-methyltransferase (ec 2.1.1.4) (hiomt) (acetylserotonin o-methyltransferase) (asmt). [source:swissprot;acc:p46597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
60.6732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
61.5778\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01491\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lats homolog 1. [source:refseq;acc:nm\_004690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
26996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28788.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
221.677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
222.489\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.00366\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
upf0183 protein. [source:swissprot;acc:q9bsu1]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2406\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l13, mitochondrial (l13mt). [source:swissprot;acc:q9byd1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
13244.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14564.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1320.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
antithrombin-iii precursor (atiii) (pro0309). [source:swissprot;acc:p01008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-binding protein precursor (lbp). [source:swissprot;acc:p18428]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
58.7808\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.9198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01487\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
methionine aminopeptidase 1 (ec 3.4.11.18) (metap 1) (map 1) (peptidase m 1). [source:swissprot;acc:p53582]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
3544.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3359.43\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
184.6\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
58.6893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.7518\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.9375\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [source:swissprot;acc:q9ujc5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
26996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28788.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transducing adaptor molecule 2; stam-like protein containing sh3 and itam domains 2. [source:refseq;acc:nm\_005843]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
182.563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.00366\vspace{3pt}}\\\hline
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2407\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s16. [source:swissprot;acc:p17008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
13244.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14564.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1320.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
methionine aminopeptidase 2 (ec 3.4.11.18) (metap 2) (peptidase m 2) (initiation factor 2 associated 67 kda glycoprotein) (p67) (p67eif2). [source:swissprot;acc:p50579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
3544.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3359.43\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
184.6\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microsomal signal peptidase 25 kda subunit (ec 3.4.-.-) (spase 25 kda subunit) (spc25). [source:swissprot;acc:q15005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.7808\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.9198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01487\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear receptor coactivator 7; estrogen receptor associated protein 140 kda. [source:refseq;acc:nm\_181782]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
26996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28788.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 3 (ec 3.4.25.1) (proteasome theta chain) (proteasome chain 13) (proteasome component c10-ii). [source:swissprot;acc:p49720]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
214.234\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.456\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.6893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.7518\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.9375\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b alpha subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q14232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2408\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast cancer type 1 susceptibility protein. [source:swissprot;acc:p38398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5454.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5637.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
183.26\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj132f21.2 (contains a novel protein similar to the l82e from drosophila) (fragment). [source:sptrembl;acc:q9h125]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
26996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28788.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
194.407\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
193.706\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.6893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.7518\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.9375\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
48.0356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1357.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1309.03\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
uridine 5'-monophosphate synthase (ump synthase) [includes: orotate phosphoribosyltransferase (ec 2.4.2.10) (oprtase); orotidine 5'- phosphate decarboxylase (ec 4.1.1.23) (ompdecase)]. [source:swissprot;acc:p11172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.7808\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.9198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01487\vspace{3pt}}\\\hline
\multirow{5}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2409\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s acidic ribosomal protein p1. [source:swissprot;acc:p05386]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4857.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5039.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
182.75\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cleft lip and palate associated transmembrane protein 1. [source:refseq;acc:nm\_001294]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Rooted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.7808\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.9198\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.01487\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58.6893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
57.7518\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.9375\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lactoylglutathione lyase (ec 4.4.1.5) (methylglyoxalase) (aldoketomutase) (glyoxalase i) (glx i) (ketone-aldehyde mutase) (s-d-lactoylglutathione methylglyoxal lyase). [source:swissprot;acc:q04760]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Ranked\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.407\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
193.706\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-alpha (liver x receptor alpha) (nuclear orphan receptor lxr-alpha). [source:swissprot;acc:q13133]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.784\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/